IndraLab

Statements



reach
"The adjusted incidence of COVID-19 hospitalisation was estimated for patients with RA; spondyloarthritis including psoriatic arthritis; connective tissue disease; vasculitides; and non IRD individuals.Further, the incidence of COVID-19 hospitalisation was estimated for patients with RA treated respectively non treated with TNF-inhibitors, hydroxychloroquine, or glucocorticoids.Lastly, the incidence of severe COVID-19 infection (intensive care, acute respiratory distress syndrome, or death) among hospital admitted patients was estimated for RA and non IRD individudals."

reach
"Of the 68 RA patients treated with HCQ, 58/68 (85%) were dramatically responsive to this medication."

reach
"As several studies suggested an association between hydroxychloroquine and lipid concentrations, Munro et al conducted a randomized one-year trial in patients with established RA where 100 patients were either treated with hydroxychloroquine (n = 51) or gold (n =."

reach
"The investigators concluded that addition of low-dose CsA was moderately effective in patients with early RA previously treated with low-dose hydroxychloroquine but with an unfavorable risk and benefi[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"A 35-year-old male patient with a medical history of chronic hepatitis c virus (genotype 1a) since 1999 and rheumatoid arthritis (RA) treated with hydroxychloroquine was examined in the hepatology unit of our Hospital."

reach
"They demonstrated that CD4 + T cells from RA patients treated with hydroxychloroquine (HCQ) showed increased levels of LC3-II and autophagosomes number compared with cells isolated from healthy donors."

reach
"A recent report found no significant differences in SF sHLA-DR in children with RA or JIA treated with MTX, HCQ, or low dose CS."

reach
"In Case 1, a 68-year-old Caucasian woman with a history of RA was initially treated with hydroxychloroquine."

reach
"Prevalence of COVID-19 in patients with rheumatoid arthritis (RA) already treated with hydroxychloroquine (HCQ) compared with HCQ-naive patients with RA : a multicentre cross-sectional study."